Mid Atlantic Bio Angels

A New York-based angel investment group focused on early-stage life science companies.

Angel Group Active New York, United States Est. 2012
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
total disclosed, rounds participated
Stages

About

Mid Atlantic Bio Angels (MABA) is a New York-based angel investor group formed in 2012. It focuses exclusively on early-stage, private life science companies, including therapeutics, devices, diagnostics, and some digital health. MABA's membership consists of accredited individuals and corporate members with expertise in scientific, regulatory, and commercial aspects of the life sciences. The group invests globally, with no geographic restrictions, and its members participate in company screenings and due diligence. MABA is not a fund; its members invest individually or as a group. They also administer internal investment pools and a co-investment Sidecar Fund.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Mid Atlantic Bio Angels' primary investment focus by sector?
Mid Atlantic Bio Angels primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and investment rounds concentrated in this area.
Can you name a notable portfolio company of Mid Atlantic Bio Angels?
A notable portfolio company of Mid Atlantic Bio Angels is FEMSelect, which develops treatments for Pelvic Floor Ligament Fixation.
What is the typical investment range for Mid Atlantic Bio Angels?
Mid Atlantic Bio Angels typically invests in the range of $900K to $9M.
What stages of funding has Mid Atlantic Bio Angels participated in?
Mid Atlantic Bio Angels has participated in A Round, B Round, and Convertible Debt funding stages.
When was Mid Atlantic Bio Angels most recently active in new investments?
Mid Atlantic Bio Angels participated in an investment round in October 2022.
What was the most recent funding round for FEMSelect, a portfolio company of Mid Atlantic Bio Angels?
FEMSelect raised a B Round totaling $16.89M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2012